Introduction Baxter 2021 Corporate Responsibility Report 6 2030 Corporate Responsibility Goals Corporate Responsibility Commitment Empower Our Patients Protect Our Planet Appendix Champion Our People and Communities Cross-Cutting Commitments COVID-19: Saving and Sustaining Lives During a Global Pandemic The ongoing COVID-19 pandemic continues to create a worldwide crisis. As a global leader in healthcare, delivering on our mission to save and sustain lives is more vital than ever. We continue to protect the health and safety of our employees; increase the supply of critically necessary products and therapies; share our industry expertise, including partnering to manufacture COVID-19 vaccines; and provide philanthropic support to communities in need. Learn more. The rollout of COVID-19 vaccines makes it possible to see light at the end of the tunnel. I’m filled with gratitude for every health professional and scientist behind this incredible global health effort. Vaccines are our best chance to protect each other and return to sharing our lives.” NEO, BUSINESS UNIT DIRECTOR FOR BAXTER RENAL CARE, ACUTE THERAPIES AND STRATEGIC INITIATIVES, HONG KONG Our People From our frontline employees in manufacturing to our clinical educators, service specialists and more, Baxter colleagues have played an extraordinary role in maintaining and increasing critical product supply to meet patient needs. Throughout the pandemic we have followed our staged response plan and continued to provide resources and ongoing communications to help employees understand the evolving science and provide up-to-date guidance in support of the health and safety of all Baxter team members, including the importance of getting the COVID-19 vaccine. See Achieve Top Quartile Workplace Safety Performance and Inclusive Pay and Benefits. Our Communities The Baxter International Foundation (the Foundation) is providing financial support to address the needs of patients, healthcare workers and communities. Since 2020, the Foundation has provided more than $3 million in global COVID-19 grants, including grants to support Feeding America, Save the Children and World Vision. Our giving included a 2:1 employee gift match campaign for Save the Children, focused on COVID-19 relief. See Invest in Underserved Communities Globally . Our Products We have boosted production to help address the elevated demand for our products around the world and made substantial investments to increase manufacturing capacity. We are partnering with vendors to procure additional raw materials to support increased production. To expedite shipping globally, we are leveraging distributor networks as well as shipping directly from our facilities. Additionally, we are working closely with governments globally to ensure ongoing manufacturing, and continuing our Manufacture-to-Donate program with humanitarian partners. See Baxter 2021 Public Policy and Political Contributions Report. Our Expertise Our medical team is working with global healthcare professionals to understand the unique clinical challenges created by COVID-19. Additionally, Baxter’s BioPharma Solutions business is providing fill/ finish manufacturing services for the Novavax, BioNTech and Moderna COVID-19 vaccines. Baxter’s BioPharma Solutions represents one entity that is part of a group of contract manufacturing partners providing fill/finish services to the market for the COVID-19 vaccine.